Evidence map›Paper›PMID 34830495›Full record

ArticleJournal of clinical medicine2021

COVID-19 Clinical Profile in Latin American Migrants Living in Spain: Does the Geographical Origin Matter?

Abiu Sempere, Fernando Salvador, Arnau Monforte, Júlia Sampol, Juan Espinosa-Pereiro, Marta Miarons, Pau Bosch-Nicolau, Alfredo Guillén-Del-Castillo, Maria Luisa Aznar, Isabel Campos-Varela and 5 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Abiu SempereDepartment of Infectious Diseases, Vall d'Hebron University Hospital, PROSICS Barcelona, 08035 Barcelona, Spain.
Fernando SalvadorDepartment of Infectious Diseases, Vall d'Hebron University Hospital, PROSICS Barcelona, 08035 Barcelona, Spain.ORCID 0000-0002-0546-1354
Arnau MonforteDepartment of Infectious Diseases, Vall d'Hebron University Hospital, PROSICS Barcelona, 08035 Barcelona, Spain.ORCID 0000-0002-5468-3885
Júlia SampolDepartment of Pneumology, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.ORCID 0000-0003-0939-7772
Juan Espinosa-PereiroDepartment of Infectious Diseases, Vall d'Hebron University Hospital, PROSICS Barcelona, 08035 Barcelona, Spain.ORCID 0000-0002-7238-8337
Marta MiaronsDepartment of Pharmacy, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
Pau Bosch-NicolauDepartment of Infectious Diseases, Vall d'Hebron University Hospital, PROSICS Barcelona, 08035 Barcelona, Spain.ORCID 0000-0002-7435-1829
Alfredo Guillén-Del-CastilloDepartment of Internal Medicine, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
Maria Luisa AznarDepartment of Infectious Diseases, Vall d'Hebron University Hospital, PROSICS Barcelona, 08035 Barcelona, Spain.ORCID 0000-0001-9223-7790
Isabel Campos-VarelaLiver Unit, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
Adrián Sánchez-MontalváDepartment of Infectious Diseases, Vall d'Hebron University Hospital, PROSICS Barcelona, 08035 Barcelona, Spain.
Lina María Leguízamo-MartínezDepartment of Pharmacovigilance and Pharmacoepidemiology, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
Inés OliveiraDepartment of Infectious Diseases, Vall d'Hebron University Hospital, PROSICS Barcelona, 08035 Barcelona, Spain.
Andrés AntónDepartment of Microbiology, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
Benito AlmiranteDepartment of Infectious Diseases, Vall d'Hebron University Hospital, PROSICS Barcelona, 08035 Barcelona, Spain.ORCID 0000-0002-1189-2361
Hebron University · PSVall d'Hebron Hospital Universitari · ESUniversitat Autònoma de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to describe and compare the clinical characteristics of hospitalized patients with COVID-19 pneumonia according to their geographical origin. This is a retrospective case-control study of hospitalized patients with confirmed COVID-19 pneumonia treated at Vall d'Hebron University Hospital (Barcelona) during the first wave of the pandemic. Cases were defined as patients born in Latin America and controls were randomly selected among Spanish patients matched by age and gender. Demographic and clinical variables were collected, including comorbidities, symptoms, vital signs and analytical parameters, intensive care unit admission and outcome at 28 days after admission. Overall, 1080 hospitalized patients were registered: 774 (71.6%) from Spain, 142 (13.1%) from Latin America and the rest from other countries. Patients from Latin America were considered as cases and 558 Spanish patients were randomly selected as controls. Latin American patients had a higher proportion of anosmia, rhinorrhea and odynophagia, as well as higher mean levels of platelets and lower mean levels of ferritin than Spanish patients. No differences were found in oxygen requirement and mortality at 28 days after admission, but there was a higher proportion of ICU admissions (28.2% vs. 20.2%,

Indexed as

COVID-19Latin AmericaSARS-CoV-2severity

Identifiers

PMID34830495
PMCPMC8622310
OpenAlexW3212812295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.